Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner
February 07, 2023 04:00 ET
|
Oxford Science Enterprises
Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner Oxford, UK: February 7, 2023 – Oxford Science Enterprises (OSE), the independent...
Imbria Presents Positive Clinical Data for Ninerafaxstat from IMPROVE-DiCE at the European Society of Cardiology Congress 2022
August 26, 2022 08:15 ET
|
Imbria Pharmaceuticals Inc.
BOSTON, Mass., Aug. 26, 2022 (GLOBE NEWSWIRE) -- Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies designed to enhance cellular energetics, today...
Blue Water Vaccines Announces Closing of Initial Public Offering
February 23, 2022 16:51 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the closing...
Blue Water Vaccines Announces Pricing of approximate $20M Initial Public Offering
February 17, 2022 19:22 ET
|
Blue Water Vaccines Inc.
CINCINNATI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines, Inc. ("BWV" or "Blue Water Vaccines" or the "Company"), a biopharmaceutical company developing vaccines, today announced the...
The Blood Connection joins nation’s first emergency blood reserve
December 02, 2021 11:25 ET
|
The Blood Connection
THE CAROLINAS AND GEORGIA, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Facing an increasingly unsteady blood supply, The Blood Connection has helped establish a first-in-the-nation partnership to prepare The...
SpyBiotech raises $32.5M in Series A funding and appoints Lutz B. Giebel as Chairman to support its novel vaccine platform through accelerated clinical development
February 10, 2021 03:00 ET
|
SpyBiotech
SpyBiotech has raised $32.5M from leading investors to advance development of its novel “plug and display” vaccine platform technologyBraavos Investment Advisers led the round, joined by new investor...
Atos s'associe à l'Université d'Oxford pour l’installation du plus grand supercalculateur IA du Royaume-Uni
August 04, 2020 04:00 ET
|
Atos International
Paris et Londres, le 4 août 2020 - Atos, leader international de la transformation digitale, a signé un contrat de quatre ans et d'une valeur de 5 millions de livres sterling avec l'Université...
Atos partners with University of Oxford on largest AI supercomputer in the UK
August 04, 2020 04:00 ET
|
Atos International
Paris and London, 4 August 2020 – Atos, a global leader in digital transformation, has signed a four-year contract worth £5 million with the University of Oxford to deliver a new, state of the art,...
ObsEva Reports Second Quarter 2019 Financial Results
August 07, 2019 01:00 ET
|
ObsEva SA
Multiple Major Milestones Expected This Year- Q4:19 Phase 3 data for IMPLANT 4 trial of nolasiban - Nolasiban MAA submission targeted for year- end 2019- Q4:19 Phase 3 data for...
Oxford BioMedica announces further capacity expansion with new facility
September 13, 2018 07:00 ET
|
Oxford BioMedica plc
Oxford BioMedica announces further capacity expansion with new facility Lentiviral vector bioprocessing market expected to grow to $800m by 2026Oxford BioMedica adds fourth facility in Oxford...